Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Acquisitions (2020 - 2025)

Health Catalyst's Acquisitions history spans 6 years, with the latest figure at -$8000.0 for Q2 2025.

  • For Q2 2025, Acquisitions fell 100.04% year-over-year to -$8000.0; the TTM value through Dec 2025 reached $41.1 million, down 48.78%, while the annual FY2025 figure was $41.1 million, 48.78% down from the prior year.
  • Acquisitions reached -$8000.0 in Q2 2025 per HCAT's latest filing, down from $41.1 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $46.8 million in Q3 2021 to a low of -$8000.0 in Q2 2025.
  • Average Acquisitions over 5 years is $23.0 million, with a median of $18.7 million recorded in 2024.
  • Peak YoY movement for Acquisitions: skyrocketed 122.86% in 2024, then tumbled 100.04% in 2025.
  • A 5-year view of Acquisitions shows it stood at $46.8 million in 2021, then plummeted by 80.03% to $9.3 million in 2022, then grew by 22.01% to $11.4 million in 2023, then skyrocketed by 122.86% to $25.4 million in 2024, then plummeted by 100.03% to -$8000.0 in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Acquisitions are -$8000.0 (Q2 2025), $41.1 million (Q1 2025), and $25.4 million (Q4 2024).